[1] |
国家卫生健康委办公厅. 原发性肝癌诊疗指南(2022年版)[J]. 中华外科杂志, 2022, 60(4):273-309.
|
|
General Office of National Health Commission. Guidelines for diagnosis and treatment of primary liver cancer(2022 edition)[J]. Chin J Surg, 2022, 60(4):273-309.
|
[2] |
国家重大疑难疾病(原发性肝癌)中西医临床协作组. 原发性肝癌中西医结合诊疗专家共识[J]. 中医药导报, 2021, 27(9):101-107.
|
|
National Clinical Collaboration Group of Chinese and Western Medicine for Major Difficult Diseases(Primary Liver Cancer). Consensus on diagnosis and treatment of primary liver cancer with integrated traditional Chinese and western medicine[J]. Guid J Tradit Chin Med Pharm, 2021, 27(9):101-107.
|
[3] |
Moss JG, Wu O, Bodenham AR, et al. Central venous access devices for the delivery of systemic anticancer therapy(CAVA):a randomised controlled trial[J]. Lancet, 2021, 398(10298):403-415.
|
[4] |
王凯蓉, 周英凤, 张晓菊, 等. 两种中心静脉输液技术的成本效果分析[J]. 中华护理杂志, 2021, 56(4):574-581.
DOI
URL
|
|
Wang KR, Zhou YF, Zhang XJ, et al. A cost-effectiveness analysis of peripherally inserted central catheter versus totally implanted venous port[J]. Chin J Nurs, 2021, 56(4):574-581.
DOI
URL
|
[5] |
马力, 刘运江, 刘荫华. 中国乳腺癌中心静脉血管通路临床实践指南(2022版)[J]. 中国实用外科杂志, 2022, 42(2):151-158.
|
|
Ma L, Liu YJ, Liu YH. Clinical practice China guidelines on central venous vascular access for breast cancer(2022 edition)[J]. Chin J Pract Surg, 2022, 42(2):151-158.
|
[6] |
Zhang JH, Ma GY, Peng S, et al. Risk factors and predictive models for peripherally inserted central catheter unplanned extubation in patients with cancer:prospective,machine learning study[J]. J Med Internet Res, 2023,25:e49016.
|
[7] |
Sun XW, Bai XM, Zhang Y, et al. Perioperative and postoperative complications of ultrasound-guided totally implantable venous access ports via the brachiocephalic vein in patients with cancer:a prospective study[J]. J Cancer, 2021, 12(5):1379-1385.
|
[8] |
叶冬青. 巢式病例对照研究的设计及分析[J]. 疾病控制杂志, 2001, 5(1):65-68.
|
|
Ye DQ. Design and analysis of nested case-control study[J]. Chin J Dis Contr Prev, 2001, 5(1):65-68.
|
[9] |
中心静脉通路上海协作组, 上海市抗癌协会实体肿瘤聚焦诊疗专委会血管通路专家委员会. 完全植入式输液港上海专家共识(2019)[J]. 介入放射学杂志, 2019, 28(12):1123-1128.
|
|
Shanghai Collaborative Group on Central Venous Access,Expert Committee on Vascular Access of Solid Tumor Focus Committee of Shanghai Anti-Cancer Association. Consensus of Shanghai experts on totally implantable access port(2019)[J]. J Interv Radiol, 2019, 28(12):1123-1128.
|
[10] |
Chinese Research Hospital Association Digestive Tumor Committee, Chinese Association of Upper Gastrointestinal Surgeons,Chinese Gastric Cancer Association and Gastrointestinal Surgical Group of Chinese Surgical Society Affiliated to the Chinese Medical Association. Chinese expert consensus and practice guideline of totally implantable access port for digestive tract carcinomas[J]. World J Gastroenterol, 2020, 26(25):3517-3527.
|
[11] |
Bertoglio S, Cafiero F, Meszaros P, et al. PICC-PORT totally implantable vascular access device in breast cancer patients undergoing chemotherapy[J]. J Vasc Access, 2020, 21(4):460-466.
DOI
PMID
|
[12] |
Tsuruta S, Goto Y, Miyake H, et al. Late complications associated with totally implantable venous access port implantation via the internal jugular vein[J]. Support Care Cancer, 2020, 28(6):2761-2768.
DOI
PMID
|
[13] |
中国中西医结合学会外周血管疾病委员会中心静脉通路专家组. 静脉输液港植入与管理多学科专家共识(2023版)[J]. 中国普通外科杂志, 2023, 32(6):799-814.
|
|
Expert Group of Central Venous Pathway,Committee of Peripheral Vascular Diseases, Chinese Society of Integrated Traditional Chinese and Western Medicine. Multidisciplinary expert consensus on implantation and management of venous infusion port(2023 edition)[J]. Chin J Gen Surg, 2023, 32(6):799-814.
|
[14] |
季学闻, 马利兵, 肉斯太木江·依马木, 等. 肝癌切除术后感染性并发症的危险因素及其预测模型的建立[J]. 中华医院感染学杂志, 2023, 33(4):542-546.
|
|
Ji XW, Ma LB, Rousitaimujiang YMM, et al. Risk factors of infectious complications after hepatectomy for hepatocellular carcinoma and the construction of its predictive model[J]. Chin J Nosocomiology, 2023, 33(4):542-546.
|
[15] |
黄晓钰, 吴丽红. 肿瘤患者输液港相关性血流感染危险因素的研究进展[J]. 四川医学, 2022, 43(7):717-721.
|
|
Huang XY, Wu LH. Research progress on risk factors of transfusion port-related bloodstream infection in tumor patients[J]. Sichuan Med J, 2022, 43(7):717-721.
|
[16] |
刘运江, 屈翔, 葛智成, 等. 乳腺癌植入式静脉输液港临床应用专家共识及技术操作指南(2017版)[J]. 中国实用外科杂志, 2017, 37(12):1377-1382.
|
|
Liu YJ, Qu X, Ge ZC, et al. Expert consensus and technical operation guide for clinical application of implantable intravenous infusion port for breast cancer(2017 edition)[J]. Chin J Pract Surg, 2017, 37(12):1377-1382.
|
[17] |
Tiegs G, Horst AK. TNF in the liver:targeting a central player in inflammation[J]. Semin Immunopathol, 2022, 44(4):445-459.
DOI
PMID
|
[18] |
Hassan SA, Palaskas N, Kim P, et al. Chemotherapeutic agents and the risk of ischemia and arterial thrombosis[J]. Curr Atheroscler Rep, 2018, 20(2):10.
DOI
PMID
|
[19] |
陈志波, 陈钦昌, 李勇辉, 等. 身体质量指数与深静脉血栓形成因果关系的孟德尔随机化研究[J]. 中华血管外科杂志, 2019, 4(4):247-251.
|
|
Chen ZB, Chen QC, Li YH, et al. Mendelian randomization study on the causal relationship between body mass index and deep vein thrombosis[J]. Chin J Vasc Surg, 2019, 4(4):247-251.
|
[20] |
温萌, 豆欣蔓, 苗晓琦, 等. 肿瘤患者完全植入式静脉输液港导管相关性血栓形成危险因素的Meta分析[J]. 中华护理杂志, 2022, 57(23):2825-2833.
DOI
URL
|
|
Wen M, Dou XM, Miao XQ, et al. Risk factors for catheter-related thrombosis in cancer patients with totally implantable venous access ports:a Meta-analysis[J]. Chin J Nurs, 2022, 57(23):2825-2833.
|
[21] |
Salim S, Zarrouk M, Elf J, et al. Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism:a population-based study[J]. J Thromb Thrombolysis, 2019, 47(4):572-577.
|
[22] |
Song X, Chen SY, Dai Y, et al. A novel incision technique of a totally implanted venous access port in the upper arm for patients with breast cancer[J]. World J Surg Oncol, 2023, 21(1):162.
DOI
PMID
|
[23] |
Santacruz E, Mateo-Lobo R, Riveiro J, et al. Infectious complications in home parenteral nutrition:a long-term study with peripherally inserted central catheters,tunneled catheters,and ports[J]. Nutrition, 2019,58:89-93.
|
[24] |
Chang TC, Yen MH, Kiu KT. Incidence and risk factor for infection of totally implantable venous access port[J]. Langenbecks Arch Surg, 2022, 407(1):343-351.
|
[25] |
鲁佳, 谢开红, 陈文思, 等. 肿瘤患者输液港相关性血栓预防及管理的最佳证据总结[J]. 中华护理杂志, 2022, 57(5):544-551.
DOI
URL
|
|
Lu J, Xie KH, Chen WS, et al. Evidence summary for the prevention and management of port-related venous thromboembolism in cancer patients[J]. Chin J Nurs, 2022, 57(5):544-551.
DOI
URL
|